The Razor's Edge
2-Year Price History
Recent Price
(12/3/2008)
$21.70
52-Week Price
$16.00 - $27.37
Market Capitalization
$43.0 Billion
Most Recent Dividend
$1.12
About Bristol-Myers Squibb Company
Bristol-Myers Squibb Company is considered to operate in the Healthcare
sector. They specifically operate in the Drug Manufacturers/Major
business segment contained within the Drugs industry.
The Company, through its divisions and subsidiaries, is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of pharmaceuticals and other health care related products.
Ockham's Rating
Rating Specific Information Withheld
Premium Access Only
BMY Revenue
As a value investing shop, we are interested in seeing how BMY's revenues measure up against past performances. One easily understandable way of doing that is to compare Price to Sales per share levels over a given time frame. Assuming it is available, Ockham prefers to look at ten years of history (for this stock there are 10 years of history available) and we weigh recent years more heavily. This allows us to find weighted average historical high and low Price to Sales ratios, which give us a better idea of the stock's current underlying value. Using this method, we have established a high range for Price to Sales of 3.42x and the low end of the range at 2.26x.
With respect to these historically rational metrics, notice that the current Price to Sales per share ratio for BMY of 1.81x is well below its normal historic Price to Sales levels. At a price of $20.70, BMY is 37% below where we would expect to see it. Clearly, this stock looks undervalued compared to historical levels, at least on a Price to Sales basis. This will positively affect our analysis because it is rare to find a stock this far below historical norms, and we would expect some price appreciation to bring this metric back towards a more normal range.
BMY Cash Earnings
Looking at BMY specifically in their Cash Earnings capabilities, Ockham views BMY as significantly below its historical average multiple of Cash Earnings. Looking at the last 10 years we can get a good understanding of what investors have grown to expect from BMY. For example, BMY's Cash Earnings ratio per share has fluctuated between 12.56 and 18.83 over this historical timeframe. This range is based upon a proprietary weighted methodology at Ockham, but can clearly show an investor where BMY is with respect to prior business periods.
So with BMY's current price (latest close of $20.70) and most recent level of Cash Earnings reported, we see significant opportunity from a value perspective. At its current price level, BMY is 47% below its average level of Price to Cash Earnings on a historical basis. This means that investors were willing to pay for a much higher stock price than currently for the same level of Cash in the past, on a relative basis. There are a couple of important things to remember, however. First, value doesn't exist in a vacuum. So if the market doesn't recognize this value, even a great disparity in Price to Cash Earnings cannot force an immediate stock price reaction. Second, patience is key when looking at securities that have reached these levels of Price to Cash Earnings versus their historical norms. So be patient with BMY.
BMY Dividends
A positive Ockham rating does not require a company to pay out an inviting dividend or a dividend at all. However, we believe dividends provide a useful measure on a company's inherent expectations.
Comparable to our analysis of Sales and Cash Earnings per share, we examine dividend yields from BMY against the historic high and low levels over an available data range. Because BMY has an established history of paying a dividend to shareholders, there is value in comparing recent dividends to historical dividends. In BMY’s case, the estimated annual dividend is $1.24 producing a current dividend yield of 5.99%. The highest dividend yield from BMY in recent history was 7.75% while the lowest dividend yield was 1.13%. It's hard not to notice that BMY pays a current dividend yield that is 34.91% above the historical median. This peaks our interest since our analysis is looks favorably upon dividend yields that are greater than the historical median.
Community Discussion